Related Experiment Video
Updated: Jun 13, 2025

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
A Role for Germline Variants in Multiple Myeloma?
1Division of Hematology Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana.
Pathogenic germline variants (PGVs) in multiple myeloma patients are linked to DNA repair genes and a history of cancer. These patients may benefit from specific treatments, suggesting germline testing is valuable.
Area of Science:
- Oncology
- Genetics
- Hematology
Background:
- Multiple myeloma is a hematologic malignancy.
- Germline variants can predispose individuals to cancer.
- Understanding genetic factors in multiple myeloma is crucial for treatment.
Purpose of the Study:
- To investigate the incidence of pathogenic germline variants (PGVs) in multiple myeloma patients.
- To identify associations between PGVs and patient characteristics or outcomes.
- To explore the therapeutic implications of PGVs in multiple myeloma.
Main Methods:
- Analysis of germline DNA in multiple myeloma patients.
- Identification and characterization of pathogenic germline variants.
- Correlation of PGVs with clinical data, including cancer history and treatment response.
Main Results:
- Pathogenic germline variants (PGVs) were identified in multiple myeloma patients, often associated with DNA repair genes like BRCA1 and BRCA2.
- Patients with PGVs reported a higher incidence of personal or family cancer history and were diagnosed at a younger age.
- PGV-positive patients demonstrated improved progression-free survival following high-dose melphalan and autologous stem cell transplant.
Conclusions:
- Germline variants in DNA repair genes are present in a subset of multiple myeloma patients.
- PGVs are associated with a history of cancer and earlier diagnosis.
- Germline genetic testing may inform therapeutic strategies, particularly for patients undergoing high-dose melphalan and autologous stem cell transplant.
More Related Videos
10:41Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
Published on: March 29, 2017
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Cancers Originate from Somatic Mutations in a Single Cell
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Histone Variants at the Centromere